As of 2025-07-12, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is (0.10) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -111.7%.
The range of the Relative Valuation is (0.08) - (0.12) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.4x | 0.3x |
| Forward P/E multiples | 0.2x - 0.4x | 0.3x |
| Fair Price | (0.08) - (0.12) | (0.10) |
| Upside | -109.4% - -114.1% | -111.7% |
| Date | P/E |
| 2025-07-10 | -2.50 |
| 2025-07-09 | -2.56 |
| 2025-07-08 | -2.53 |
| 2025-07-07 | -2.50 |
| 2025-07-04 | -2.65 |
| 2025-07-03 | -2.62 |
| 2025-07-02 | -2.53 |
| 2025-06-30 | -2.47 |
| 2025-06-27 | -2.41 |
| 2025-06-26 | -2.65 |
| 2025-06-25 | -2.65 |
| 2025-06-24 | -2.47 |
| 2025-06-23 | -2.53 |
| 2025-06-20 | -2.53 |
| 2025-06-19 | -2.65 |
| 2025-06-17 | -2.65 |
| 2025-06-16 | -2.62 |
| 2025-06-13 | -2.62 |
| 2025-06-12 | -2.68 |
| 2025-06-11 | -2.70 |
| 2025-06-10 | -2.73 |
| 2025-06-09 | -2.65 |
| 2025-06-06 | -2.65 |
| 2025-06-05 | -2.53 |
| 2025-06-04 | -2.65 |
| 2025-06-03 | -2.73 |
| 2025-06-02 | -2.79 |
| 2025-05-30 | -2.76 |
| 2025-05-29 | -2.97 |
| 2025-05-28 | -2.91 |
| 2025-05-27 | -3.02 |
| 2025-05-26 | -3.08 |
| 2025-05-23 | -3.02 |
| 2025-05-22 | -3.20 |
| 2025-05-21 | -3.34 |
| 2025-05-20 | -3.32 |
| 2025-05-16 | -3.29 |
| 2025-05-15 | -3.11 |
| 2025-05-14 | -3.05 |
| 2025-05-13 | -3.20 |
| 2025-05-12 | -3.29 |
| 2025-05-09 | -3.08 |
| 2025-05-08 | -2.91 |
| 2025-05-07 | -2.76 |
| 2025-05-06 | -2.91 |
| 2025-05-05 | -3.02 |
| 2025-05-02 | -3.05 |
| 2025-05-01 | -3.55 |
| 2025-04-30 | -3.37 |
| 2025-04-29 | -3.20 |